1. Home
  2. WTO vs CDT Comparison

WTO vs CDT Comparison

Compare WTO & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTO
  • CDT
  • Stock Information
  • Founded
  • WTO 2008
  • CDT 2019
  • Country
  • WTO China
  • CDT United States
  • Employees
  • WTO N/A
  • CDT N/A
  • Industry
  • WTO Consumer Electronics/Appliances
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • WTO Technology
  • CDT Health Care
  • Exchange
  • WTO Nasdaq
  • CDT Nasdaq
  • Market Cap
  • WTO 8.0M
  • CDT 7.1M
  • IPO Year
  • WTO 2021
  • CDT N/A
  • Fundamental
  • Price
  • WTO $0.30
  • CDT $0.07
  • Analyst Decision
  • WTO
  • CDT
  • Analyst Count
  • WTO 0
  • CDT 0
  • Target Price
  • WTO N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • WTO 1.4M
  • CDT 101.0M
  • Earning Date
  • WTO 02-24-2025
  • CDT 02-14-2025
  • Dividend Yield
  • WTO N/A
  • CDT N/A
  • EPS Growth
  • WTO N/A
  • CDT N/A
  • EPS
  • WTO N/A
  • CDT N/A
  • Revenue
  • WTO $32,309,502.00
  • CDT N/A
  • Revenue This Year
  • WTO N/A
  • CDT N/A
  • Revenue Next Year
  • WTO N/A
  • CDT N/A
  • P/E Ratio
  • WTO N/A
  • CDT N/A
  • Revenue Growth
  • WTO 44.56
  • CDT N/A
  • 52 Week Low
  • WTO $0.25
  • CDT $0.05
  • 52 Week High
  • WTO $62.25
  • CDT $3.92
  • Technical
  • Relative Strength Index (RSI)
  • WTO 42.28
  • CDT 45.83
  • Support Level
  • WTO $0.28
  • CDT $0.08
  • Resistance Level
  • WTO $0.35
  • CDT $0.18
  • Average True Range (ATR)
  • WTO 0.05
  • CDT 0.02
  • MACD
  • WTO 0.01
  • CDT 0.00
  • Stochastic Oscillator
  • WTO 12.64
  • CDT 11.90

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: